Skip to content

Clinical trials

Phase 2 Epstein-Barr Virus Infections trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epstein-Barr Virus Infections Phase: Phase 2 Country / region: France Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated2
Active, not recruiting1
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene1
Cell Medica Ltd1
Pierre Fabre Medicament1
Viracta Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epstein-Barr Virus Infections4
Head and Neck Neoplasms1
Immunologic Deficiency Syndromes1
Leiomyosarcoma1
Lymphoma, Extranodal NK-T-Cell1
Lymphoproliferative Disorders1
Nasopharyngeal Carcinoma1
Nasopharyngeal Neoplasms1
Neoplasm Metastasis1
Neoplasms1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.